about
Genetic variation of αENaC influences lung diffusion during exercise in humans.Genetic variation of the alpha subunit of the epithelial Na+ channel influences exhaled Na+ in healthy humans.Impaired cardiac and peripheral hemodynamic responses to inhaled β₂-agonist in cystic fibrosis.The relationship between cardiac hemodynamics and exercise tolerance in cystic fibrosisModerate intensity exercise mediates comparable increases in exhaled chloride as albuterol in individuals with cystic fibrosis.Albuterol Improves Alveolar-Capillary Membrane Conductance in Healthy Humans.Genetic variation of SCNN1A influences lung diffusing capacity in cystic fibrosis.Relaxation breathing improves human glycemic response.Aerobic capacity is associated with improved repeated shift performance in hockey.Effects of exercise intensity compared to albuterol in individuals with cystic fibrosis.Aging Alters the Relative Contributions of the Sympathetic and Parasympathetic Nervous System to Blood Pressure Control in WomenCystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic FibrosisExercise Stroke Volume in Adult Cystic Fibrosis: A Comparison of Acetylene Pulmonary Uptake and Oxygen PulsePsychological and Genetic Predictors of Pain Tolerance.Sex differences in paediatric airway anatomyForearm vasodilatation to a β2 -adrenergic receptor agonist in premenopausal and postmenopausal womenSex differences in large conducting airway anatomyThe role of the paravertebral ganglia in human sympathetic neural discharge patternsDissociating the effects of oxygen pressure and content on the control of breathing and acute hypoxic responseSex differences in youth elite swimmingAsynchronous action potential discharge in human muscle sympathetic nerve activityEffect of varying chemoreflex stress on sympathetic neural recruitment strategies during apneaInfluence of high affinity haemoglobin on the response to normoxic and hypoxic exercise
P50
Q35549555-48CDC53F-F473-4B8E-B6AA-7E429E25A55AQ35549587-CF638176-0AEF-4099-A65E-C2AB66818CEAQ36030535-B7324A92-7713-4F3B-9AE9-6EC8D15927F9Q36880402-21000C82-18D5-4272-AD01-400ADA446BEDQ37087501-65320BD2-E2A4-4AE6-85F6-1D6D9F30E1ABQ37338441-4DA76D1F-7AA6-4CA5-9300-61BB416A7789Q41510380-8D34207D-0847-4717-B0D8-8E8C2A6B4837Q43480852-3F4A9D1D-B7A6-438D-A145-160323FBC9BDQ50950271-D1EE2516-B247-47F5-9FB8-6C6E3D911EA7Q51651940-E8E13FFE-5C2D-4D7A-96EF-66B726669443Q57787264-262E7D38-0F1C-4830-A0F8-A69314F702ADQ64101552-A9FB652C-82E0-4B39-95EA-B481E4BE3948Q64325157-D86E3FB8-2D7D-4221-BAA1-18D19FA83572Q64914154-A247E43D-38BF-4568-80B3-EBBC8386D77EQ89463491-173B31FA-46AB-4022-91E5-6968B5082D70Q90322328-268449A9-62EE-4CAA-BE8B-A81ED6D1EA8DQ90338268-3690FD27-BF96-4A86-AE9A-EEFA9065D6D6Q90583980-78CA0EA8-7D38-4F19-AD67-5088052F637FQ90922180-354131C6-F276-4E06-B71D-1EABDF503629Q91396176-AA23F2E7-AC0A-4C8B-A94F-80C0912F5D0DQ92364225-98149865-1A53-423A-9A35-D0761B7FD16DQ92472081-F8313BF7-731E-44CC-B142-6B21D40AAB92Q92554214-27E2BD30-2B5D-432E-BB45-5C49641FDFA1
P50
description
investigador
@es
researcher
@en
name
Sarah E Baker
@en
type
label
Sarah E Baker
@en
prefLabel
Sarah E Baker
@en
P31
P496
0000-0001-9647-7660